PHARMA & SCIENCE
THE SYNOPSIS
- The pharma sector is increasingly becoming a prime target for cybercriminals due to the value of its data and the sensitive information it handles.
- This includes data on clinical trials, intellectual property, patient information, and financial records. Additionally, there is a significant lack of cybersecurity protection in the pharma sector, which makes it very vulnerable to cyberattacks.
- The consequences of a successful cyberattack on the pharma sector can be devastating, ranging from financial loss and damage to the company’s reputation to public safety risks.
- Cybersecurity risks in the pharma sector require attention at every level, from individual employees to the company’s leadership, and effective measures must be put in place to mitigate such threats.
- Companies must prioritize cybersecurity efforts and invest in robust security measures to safeguard their data and systems from cyber threats.
THE PROBLEM
- Pharma and scientific research institutions rely heavily on digital data storage and communication.
- This dependence on technology poses a significant threat as cyber-attacks have become more sophisticated, frequent and devastating.
- The consequences of a successful cyber-attack could be catastrophic for pharma and scientific research institutions, as they can lose their valuable intellectual property, confidential patient data, and research findings.
- Moreover, unlike other industries, the pharma and scientific research sectors have longer research and development cycles, which means that the potential damage caused by cyber-attacks will last longer and, in some cases, may lead to delayed research outcomes.
- Thus, the problem of cybersecurity is of utmost importance to these institutions, and they must take necessary precautions to protect themselves against these threats.
- This includes investing in robust cybersecurity measures, adopting cybersecurity best practices, and raising awareness among the employees.